Preview

Current Pediatrics

Advanced search

HYPERTROPHIC CARDIOMYOPATHY AS A PART OF INHERITED MALFORMATION SYNDROMES IN INFANTS

Abstract

The data of clinical and instrumental examination of two infantile patients with obstructive hypertrophic cardiomyopathy in association with marked multisystem involvement as a picture of inherited malformation syndromes are given.
Key words: infants, hypertrophic cardiomyopathy, LEOPARD syndrome, Noonan syndrome.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2011; 10 (3): 166–169)

About the Authors

M.V. Tural'chuk
St.-Petersburg State Pediatric Medical Academy


G.A. Novik
St.-Petersburg State Pediatric Medical Academy


A.Ya. Gudkova
I.P. Pavlov St.-Petersburg State Medical University


References

1. Maron В.J., McKenna W.J. et al. ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy. JACC. 2003; 42: 1–27.

2. Keren А., Syrris Р., McKennaW.J. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med. 2008; 5 (3): 158–168.

3. Colan S.D., Lipshultz S.E., Lowe A.M. et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children findings from the pediatric cardiomyopathy registry. Circulation. 2007; 115: 773–781.

4. Hoffmann B., Mayatepek E. Fabry disease-often seen, rarely diagnosed. Dtsch. Arztebl. Int. 2009; 106 (26): 440–447.

5. Veinot J.P. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002; 106 (15): 1407–1411.

6. Chimenti C., Pieroni M. et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004; 110 (9): 1047–1053.

7. Maron В.J., Seidman C.E., Ackerman M.J. et al. How should hypertrophic cardiomyopathy be classified? What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy. Circ. Cardiovasc. Genet. 2009; 2 (1): 81–85.

8. Wilkinson J.D., Sleeper L.A., Alvarez J.A. еt al. The Pediatric Cardiomyopathy Registry: 1995–2007. Prog. Pediatr. Cardiol. 2008; 25 (1): 31–36.

9. Gelb B.D., Tartaglia M. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum. Mol. Genet. 2006; 15 (2): 220–226.

10. Digilio M.C., Conti E., Sarkozy A. et al. Grouping of multiple lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am. J. Hum. Genet. 2002; 71 (2): 389–394.

11. Sarkozy A., Conti E., Digilio M.C. et al. Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J. Med. Genet. 2004; 41 (5): e68.

12. Sarkozy A., Digilio M.C., Dallapiccola B. Leopard syndrome. Orphanet J. Rare Dis. 2008; 3: 1–8.

13. Allanson J.E. Noonan syndrome. Am. J. Med. Genet. C. Semin. Med. Genet. 2007; 145: 274–279.

14. Gibson W., Trevenen C., Giuffre M., Leung A.K. Noonan syndrome in a premature infant with hypertrophic cardiomyopathy and death in infancy. J. Natl. Med. Assoc. 2005; 97 (6): 805–807.

15. Cerrato F., Pacileo G., Limongelli G. et al. A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes. Cardiol. Young. 2008; 18 (6): 575–580.

16. Formigari R., Michielon G., Digilio M.C. et al. Genetic syndromes and congenital heart defects: how is surgical management affected? Eur. J. Cardiothorac. Surg. 2009; 35 (4): 606–614.

17. Arad M., Maron B.J., Gorham J.M. et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 2005; 352 (4): 362–372.


Review

For citations:


Tural'chuk M., Novik G., Gudkova A. HYPERTROPHIC CARDIOMYOPATHY AS A PART OF INHERITED MALFORMATION SYNDROMES IN INFANTS. Current Pediatrics. 2011;10(3):166–169.

Views: 496


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)